Serum MUC-1 as a marker of disease status in multiple myeloma patients receiving thalidomide.
Mileshkin
Linda
L
Prince
H M
HM
Seymour
J F
JF
Biagi
J J
JJ
D015415:Biomarkers / Q000097:blood; D018450:Disease Progression; D005500:Follow-Up Studies; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D008565:Membrane Proteins / Q000097:blood*; D009101:Multiple Myeloma / Q000097:blood*; D011446:Prospective Studies; D013792:Thalidomide / Q000627:therapeutic use*
D015415:Biomarkers; D007166:Immunosuppressive Agents; D008565:Membrane Proteins; D013792:Thalidomide